The clinical course of patients with idiopathic pulmonary fibrosis
- PMID: 15968010
- DOI: 10.7326/0003-4819-142-12_part_1-200506210-00005
The clinical course of patients with idiopathic pulmonary fibrosis
Abstract
Background: Prospective data defining the clinical course in idiopathic pulmonary fibrosis (IPF) are sparse.
Objective: To analyze the clinical course of patients with mild to moderate IPF.
Design: Analysis of data from the placebo group of a randomized, controlled trial evaluating interferon-gamma1b.
Setting: Academic and community medical centers.
Patients: 168 patients in the placebo group of a trial evaluating interferon-gamma1b.
Measurements: Measures of physiology and dyspnea assessed at 12-week intervals; hospitalizations; and the pace of deterioration and cause of death over a median period of 76 weeks.
Results: Physiologic variables changed minimally during the study. However, 23% of patients required hospitalization for a respiratory disorder and 21% died. Idiopathic pulmonary fibrosis was the primary cause of death in 89% of patients who died, and an apparent acute clinical deterioration preceded death in 47% of these patients.
Limitations: The instrument used to define the pace of deterioration and cause of death was applied retrospectively.
Conclusions: Recognition of the common occurrence of acute fatal deterioration in patients with mild to moderate IPF has important implications for monitoring patients and supports early referral for lung transplantation.
Comment in
-
Acute exacerbations in idiopathic pulmonary fibrosis.Ann Intern Med. 2006 Feb 7;144(3):218; author reply 218-9. doi: 10.7326/0003-4819-144-3-200602070-00014. Ann Intern Med. 2006. PMID: 16461970 No abstract available.
Summary for patients in
-
Summaries for patients. What is the natural course of idiopathic pulmonary fibrosis?Ann Intern Med. 2005 Jun 21;142(12 Pt 1):I23. doi: 10.7326/0003-4819-142-12_part_1-200506210-00002. Ann Intern Med. 2005. PMID: 15968007 No abstract available.
Similar articles
-
Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis?Eur Respir J. 2003 Dec;22(6):906-11. doi: 10.1183/09031936.03.00091802. Eur Respir J. 2003. PMID: 14680077
-
Summaries for patients. What is the natural course of idiopathic pulmonary fibrosis?Ann Intern Med. 2005 Jun 21;142(12 Pt 1):I23. doi: 10.7326/0003-4819-142-12_part_1-200506210-00002. Ann Intern Med. 2005. PMID: 15968007 No abstract available.
-
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.Am J Respir Crit Care Med. 2017 Sep 15;196(6):756-761. doi: 10.1164/rccm.201701-0091OC. Am J Respir Crit Care Med. 2017. PMID: 28471697 Free PMC article.
-
Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment.Am J Med. 1990 Apr;88(4):396-404. doi: 10.1016/0002-9343(90)90495-y. Am J Med. 1990. PMID: 2183601 Review.
-
Idiopathic pulmonary fibrosis: current concepts.Mayo Clin Proc. 1998 Nov;73(11):1085-101. doi: 10.4065/73.11.1085. Mayo Clin Proc. 1998. PMID: 9818046 Review.
Cited by
-
Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis.Int J Med Sci. 2022 Aug 15;19(9):1417-1429. doi: 10.7150/ijms.73305. eCollection 2022. Int J Med Sci. 2022. PMID: 36035368 Free PMC article.
-
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF).Expert Rev Clin Pharmacol. 2024 Sep;17(9):817-835. doi: 10.1080/17512433.2024.2396121. Epub 2024 Aug 27. Expert Rev Clin Pharmacol. 2024. PMID: 39192604 Review.
-
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.JAMA. 2013 Jun 5;309(21):2232-9. doi: 10.1001/jama.2013.5827. JAMA. 2013. PMID: 23695349 Free PMC article.
-
Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.Am J Physiol Lung Cell Mol Physiol. 2012 Dec 15;303(12):L1046-56. doi: 10.1152/ajplung.00139.2012. Epub 2012 Oct 5. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 23043074 Free PMC article.
-
The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumonia.PLoS One. 2019 Aug 19;14(8):e0212810. doi: 10.1371/journal.pone.0212810. eCollection 2019. PLoS One. 2019. PMID: 31425562 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical